Here are the top stories from the last week:
Industry Updates
CRN Warns Against Vitamin A Misuse for Measles Prevention
The Council for Responsible Nutrition (CRN) expressed concern over reports of misusing high-dose vitamin A, particularly for children. Read article »
HHS to Cut 10,000 Jobs in Sweeping Reorganization
“We aren’t just reducing bureaucratic sprawl,” said HHS Secretary Robert F. Kennedy, Jr. “We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic.” Read article »
Senate Committee Advances Dr. Oz’s Nomination to Lead CMS
The Senate Finance Committee voted 14-13 along party lines to advance Oz’s nomination to lead the Centers for Medicare and Medicaid Services to the full Senate for a vote. Read article »
LillyDirect Platform Expands to Improve Access to Alzheimer’s Care
Eli Lilly and Company enhances digital healthcare offerings to address delays in Alzheimer’s diagnosis and treatment. Read article »
Cardinal Health Accelerating Use of AI in Digital and Commercial Technologies
With its AI Center of Excellence, Cardinal Health promises to identify promising use cases for the application of AI technologies. Read article »
Trump Nominates Susan Monarez to Head CDC
If confirmed by the Senate, Monarez would be the first non-physician to lead the Centers for Disease Control in more than 50 years. Read article »
CVS Rx Report: A Tech-Enabled Pharmacy Experience Offers Convenient Care
The report found that digital tools play an important role in enhancing the patient experience, but patients and pharmacy teams also value personal interactions. Read article »
Why Pen Needle Selection and Usage Counseling Matters
The article highlights the importance of proper pen needle selection and usage for optimal glycemic control and medication delivery. Read article »
Drug Updates
Dupilumab May Decrease IgE Levels in Patients with Comorbid Food Allergies
A new study found that Dupilumab (Dupixent, Sanofi, Regeneron) was associated with significant reductions in food-specific immunoglobulin E (IgE) levels at 12 and 24 months and helped patients pass food allergy challenges. Read article »
FDA Drug Approvals Dip 15.4% in 2024, but Smaller Pharma Leads Innovation
Despite the approval decrease, the landscape of pharmaceutical transformation remains vibrant with smaller companies leading the way. Read article »
Novo Nordisk Expands Wegovy Monthly Offer
Originally only available through the company’s NovoCare Pharmacy, Novo Nordisk is now expanding its $499/month Wegovy offering to patients at participating local pharmacies. Read article »